Charles Frenette
Overview
Explore the profile of Charles Frenette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rudnick W, Conly J, Thirion D, Choi K, Pelude L, Cayen J, et al.
Antimicrob Resist Infect Control
. 2023 Apr;
12(1):35.
PMID: 37072874
Background: Antimicrobial resistance threatens the ability to successfully prevent and treat infections. While hospital benchmarks regarding antimicrobial use (AMU) have been well documented among adult populations, there is less information...
12.
Lefebvre M, Rajda E, Frenette C, Paquet F, Rubin E, Sleno H, et al.
Am J Infect Control
. 2023 Feb;
51(8):961-963.
PMID: 36736901
The incidence of healthcare-associated viral respiratory infections in a pediatric hospital decreased from 1.6 /1,000 patient-days in 2019 to 0.2 /1,000 patient-days in 2020 (P < .01), and this was...
13.
Thirion D, Caissy J, Poulin F, Lanfranchi C, Deda A, Aprikian A, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671257
The purpose of this study was to evaluate the impact of augmented prophylaxis (ciprofloxacin augmented with an aminoglycoside) compared with that of empirical prophylaxis (ciprofloxacin alone) on transrectal post-prostate biopsy...
14.
Loeb M, Bartholomew A, Hashmi M, Tarhuni W, Hassany M, Youngster I, et al.
Ann Intern Med
. 2022 Nov;
175(12):1629-1638.
PMID: 36442064
Background: It is uncertain if medical masks offer similar protection against COVID-19 compared with N95 respirators. Objective: To determine whether medical masks are noninferior to N95 respirators to prevent COVID-19...
15.
Li J, Frenette C, Loo V
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
7(3):181-185.
PMID: 36337610
Background: The detection rate of SARS-CoV-2 by polymerase chain reaction (PCR) varies depending on the time since exposure and is highest around the time of symptom onset. It is conceivable...
16.
Valerio V, Rampakakis E, Zanos T, Levy T, Shen H, McDonald E, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146592
We assessed the frequency and correlates of COVID-19 vaccine hesitancy before Canada's vaccine rollout. A cross-sectional vaccine hesitancy survey was completed by consecutive patients/family members/staff who received the influenza vaccine...
17.
Choi K, Du T, Silva A, Golding G, Pelude L, Mitchell R, et al.
Infect Control Hosp Epidemiol
. 2022 Aug;
44(7):1180-1183.
PMID: 35978535
The coronavirus disease 2019 (COVID-19) pandemic has placed significant burden on healthcare systems. We compared infection (CDI) epidemiology before and during the pandemic across 71 hospitals participating in the Canadian...
18.
Du T, Choi K, Silva A, Golding G, Pelude L, Hizon R, et al.
Emerg Infect Dis
. 2022 Apr;
28(6):1128-1136.
PMID: 35470794
We investigated epidemiologic and molecular characteristics of healthcare-associated (HA) and community-associated (CA) Clostridioides difficile infection (CDI) among adult patients in Canadian Nosocomial Infection Surveillance Program hospitals during 2015-2019. The study...
19.
Liang J, Rudnick W, Mitchell R, Brooks J, Bush K, Conly J, et al.
Infect Control Hosp Epidemiol
. 2022 Mar;
43(11):1558-1564.
PMID: 35249564
Objectives: The Canadian Nosocomial Infection Surveillance Program conducted point-prevalence surveys in acute-care hospitals in 2002, 2009, and 2017 to identify trends in antimicrobial use. Methods: Eligible inpatients were identified from...
20.
Almomen A, Cox J, Lebouche B, Cheng M, Frenette C, Routy J, et al.
AIDS Res Hum Retroviruses
. 2022 Feb;
38(5):359-362.
PMID: 35172609
We performed retrospective chart reviews and described the clinical characteristics, exposure risks, and disease severity of people living with HIV (PLWH) attending the Chronic Viral Illness Service (CVIS) in Montreal,...